Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001600136-25-000011
Filing Date
2025-11-26
Accepted
2025-11-26 10:15:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8031
2 exhibit1jointfilingagreement.htm EX-1 4045
  Complete submission text file 0001600136-25-000011.txt   13955
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-39444 | Film No.: 251525493
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 750 LEXINGTON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE, 25TH FLOOR NEW YORK NY 10022 212-735-5380
Clearline Capital LP (Filed by) CIK: 0001600136 (see all company filings)

EIN.: 900934356 | State of Incorp.: DE | Fiscal Year End: 0213
Type: SCHEDULE 13G